Pictet Asset Management (UK)’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Pictet Asset Management (UK)’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-180,544	Closed	-$7.64M	–	1585
2020 Q2	$7.64M	Buy	180,544 +3,393	+2%	+$110K	0.01%	581
2020 Q1	$4.89M	Sell	177,151 -18,045	-9%	-$526K	0.01%	647
2019 Q4	$6.33M	Buy	195,196 +74,830	+62%	+$2.32M	0.01%	699
2019 Q3	$3.13M	Buy	120,366 +11,896	+11%	+$398K	0.01%	798
2019 Q2	$3.98M	Buy	+108,470	New	+$2.6M	0.01%	753

Other funds holding ODT

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Pictet Asset Management (UK)'s ODT Position: Q3 2020 in Review

Pictet Asset Management (UK) sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q3 2020, closing a stake of 180,544 shares — an estimated $7.64M sold.

Pictet Asset Management (UK) first reported a position in ODT in Q2 2019 and held it in 5 quarters. The position peaked at $7.64M in Q2 2020. 89 funds tracked by Wall St. Rank hold ODT as of Q3 2020.

Pictet Asset Management (UK) reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Pictet Asset Management (UK) sold 180,544 Odonate Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $7.64M.
Pictet Asset Management (UK) first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2019 and held it in 5 quarters.
Pictet Asset Management (UK)'s Odonate Therapeutics, Inc. Common Stock position peaked at $7.64M in Q2 2020.
89 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q3 2020.

Based on Pictet Asset Management (UK)'s 13F filing for Q3 2020, filed 12 Nov 2020.